U-Chart Analysis:BrightPath Biotherapeutics Co., Ltd.:4594

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index BrightPath Biotherapeutics Co., Ltd. 4594 Medicals 東証グロース March 1, 2000 2015.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

BrightPath Biotherapeutics Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2023年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2022年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2021年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 1,531 2,305 3,265 3,018 4,901
Other Current AssetsHelp 120 391 386 310 260
Tangible Fixed AssetsHelp 0 25 48 97 91
Intangible Fixed AssetHelp 0 0 0 0 0
Investments and OthersHelp 50 50 50 49 52
Total AssetsHelp 1,701 2,771 3,749 3,475 5,304
Total Current LiabilitiesHelp 134 240 212 239 208
Total Long-term LiabilitiesHelp 0 0 0 0 0
Shareholder's EquityHelp 1,568 2,531 3,538 3,235 5,096
Total LiabilitiesHelp 1,701 2,771 3,749 3,475 5,304

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2023年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2022年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2021年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 5 15 3 11 156
Total Sales 5 15 3 11 156
Cost of SalesHelp 2 3 1 4 71
Other Costs and RevenueHelp 1,489 1,496 1,721 1,865 1,969
Total CostsHelp 1,491 1,500 1,722 1,869 2,040
Net RevenueHelp 3 12 1 7 85
Earnings Before TaxHelp -1,484 -1,482 -1,717 -1,860 -1,881
Net IncomeHelp -1,486 -1,484 -1,720 -1,858 -1,884
Net Income -1,486 -1,484 -1,720 -1,858 -1,884

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2023年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2022年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2021年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2020年3月期 BrightPath Biotherapeutics Co., Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help -1,204 -1,512 -1,770 -1,784 -1,458
Investing Cash Flow(ICF)Help -2 -18 -36 -107 -185
Financing Cash FlowHelp 432 569 2,053 9 16
Exchange Difference of Cash and Cash EquivalentsHelp 0 0 -0 0 -0
Net Increase and Decrease in Cash and Cash Equivalentsn -774 -960 247 -1,883 -1,627

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

BrightPath Biotherapeutics Co., Ltd.

Company where related level is highHelp

DAIICHI SANKYO COMPANY, LIMITED
WAKAMOTO PHARMACEUTICAL CO.,LTD.
KISSEI PHARMACEUTICAL CO.,LTD.
NIPPON CHEMIPHAR CO.,LTD.
SAWAI GROUP HOLDINGS Co., Ltd.
TOWA PHARMACEUTICAL CO.,LTD.
RaQualia Pharma Inc.
RIBOMIC Inc.
ONO PHARMACEUTICAL CO.,LTD.
Delta-Fly Pharma,Inc.